Weixiang Bian
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 1
-
- Ubiquitin and proteasome pathways 4
- Developmental Biology and Gene Regulation 2
- Glycosylation and Glycoproteins Research 1
- bioluminescence and chemiluminescence research 1
-
- Acute Myeloid Leukemia Research 1
-
- Cancer Research and Treatments 1
-
- Advanced Proteomics Techniques and Applications 1
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Cell Research (1 paper)FEBS Letters (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weixiang Bian
10 papers receiving 455 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Infectious Diseases 257
- Immunology 102
- Neurology 50
- Cancer Research 42
- Molecular Biology 171
Countries citing papers authored by Weixiang Bian
This map shows the geographic impact of Weixiang Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang Bian more than expected).
Fields of papers citing papers by Weixiang Bian
This network shows the impact of papers produced by Weixiang Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang Bian. The network helps show where Weixiang Bian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weixiang Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 38 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 9 | |
| 8 | AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cellsbreakdown → | 2021 | 334 |
| 9 | 2021 | 26 | |
| 10 | 2017 | 7 | |
| 11 | 2016 | 11 | |
| 12 | 2015 | 3 |
About Weixiang Bian
Weixiang Bian is a scholar working on Molecular Biology, Cell Biology and Biotechnology, having authored 12 papers that have together received 460 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Developmental Biology and Gene Regulation (2 papers), Glycosylation and Glycoproteins Research (1 paper), Acute Myeloid Leukemia Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Cancer Research and Treatments (1 paper), bioluminescence and chemiluminescence research (1 paper) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Infectious Diseases (257 citations), Immunology (102 citations) and Neurology (50 citations). Weixiang Bian has collaborated with scholars based in China and United States. Frequent co-authors include Xu Li, Shaofang Xie, Aifu Lin, Yingnan Hou, Qiang Zhou, Youhua Xie, Chong Zhang, Chao Shan, Tingting Zheng and Zewei Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell Research, FEBS Letters, Cell Reports and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.